Autologous SLAMF7 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous SLAMF7 CAR-T cells, covering 2024-04-25 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma [Phase 1, Phase 2]